266 related articles for article (PubMed ID: 2687694)
1. The relative contribution of resident pulmonary alveolar macrophage and inflammatory polymorphonuclear neutrophils in host resistance to pulmonary infection by Candida albicans.
Sawyer RT; Harmsen AG
Mycopathologia; 1989 Nov; 108(2):95-105. PubMed ID: 2687694
[TBL] [Abstract][Full Text] [Related]
2. Experimental pulmonary candidiasis.
Sawyer RT
Mycopathologia; 1990 Feb; 109(2):99-109. PubMed ID: 2183066
[TBL] [Abstract][Full Text] [Related]
3. Cytosolic phospholipase A2 contributes to innate immune defense against Candida albicans lung infection.
Jayaraja S; Dakhama A; Yun B; Ghosh M; Lee H; Redente EF; Uhlson CL; Murphy RC; Leslie CC
BMC Immunol; 2016 Aug; 17(1):27. PubMed ID: 27501951
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary defence mechanism in mice. A comparative role of alveolar macrophages and polymorphonuclear cells against infection with Candida albicans.
Lal S; Mitsuyama M; Miyata M; Ogata N; Amako K; Nomoto K
J Clin Lab Immunol; 1986 Mar; 19(3):127-33. PubMed ID: 3519975
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of cyclophosphamide and cortisone acetate on bronchoalveolar phagocytic cell populations.
Pennington JE
Am Rev Respir Dis; 1978 Aug; 118(2):319-24. PubMed ID: 697182
[TBL] [Abstract][Full Text] [Related]
6. Production of tumor necrosis factor-alpha in granulocytopenic mice with pulmonary candidiasis and its modification with granulocyte colony-stimulating factor.
Futenma M; Kawakami K; Saito A
Microbiol Immunol; 1995; 39(6):411-7. PubMed ID: 8551973
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary tissue resistance to Candida albicans in normal and in immunosuppressed mice.
Nugent KM; Onofrio JM
Am Rev Respir Dis; 1983 Nov; 128(5):909-14. PubMed ID: 6638681
[TBL] [Abstract][Full Text] [Related]
8. Vaginal Heparan Sulfate Linked to Neutrophil Dysfunction in the Acute Inflammatory Response Associated with Experimental Vulvovaginal Candidiasis.
Yano J; Noverr MC; Fidel PL
mBio; 2017 Mar; 8(2):. PubMed ID: 28292981
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of Candida albicans infections of haematogenous and mucosal origin in mice lacking the interferon gamma receptor protein.
Londono LP; Jones HB; Vie AT; McPheat WL; Booth G; Gao XM; Dougan G
FEMS Immunol Med Microbiol; 2000 Feb; 27(2):117-25. PubMed ID: 10640606
[TBL] [Abstract][Full Text] [Related]
10. Enhanced clearance of Candida albicans from lung after intratracheal immunization.
Lal S; Mitsuyama M; Amako K; Nomoto K
J Clin Lab Immunol; 1986 Sep; 21(1):23-30. PubMed ID: 3543372
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive effect of cyclosporin A on resistance to systemic infection with Candida albicans.
Vecchiarelli A; Cenci E; Marconi P; Rossi R; Riccardi C; Bistoni F
J Med Microbiol; 1989 Nov; 30(3):183-92. PubMed ID: 2511321
[TBL] [Abstract][Full Text] [Related]
12. Role of polymorphonuclear leukocytes in the resistance of tumor-bearing mice against Candida albicans infection.
Okawa Y; Kobayashi M; Sakai K; Suzuki M
Biol Pharm Bull; 2004 May; 27(5):674-8. PubMed ID: 15133243
[TBL] [Abstract][Full Text] [Related]
13. Experimental pulmonary candidiasis in modified rabbits. Histopathological, ultrastructural and enzyme cytochemical studies of tissue reactions.
Nakamura T
Mycopathologia; 1984 Apr; 85(3):129-44. PubMed ID: 6738666
[TBL] [Abstract][Full Text] [Related]
14. Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice.
Kullberg BJ; van 't Wout JW; Hoogstraten C; van Furth R
J Infect Dis; 1993 Aug; 168(2):436-43. PubMed ID: 8335982
[TBL] [Abstract][Full Text] [Related]
15. Effector function of leucocytes from susceptible and resistant mice against distinct isolates of Candida albicans.
Hu Y; Farah CS; Ashman RB
Immunol Cell Biol; 2006 Oct; 84(5):455-60. PubMed ID: 16869942
[TBL] [Abstract][Full Text] [Related]
16. Interaction and intracellular killing of Candida albicans blastospores by human polymorphonuclear leucocytes, monocytes and monocyte-derived macrophages in aerobic and anaerobic conditions.
Thompson HL; Wilton JM
Clin Exp Immunol; 1992 Feb; 87(2):316-21. PubMed ID: 1310454
[TBL] [Abstract][Full Text] [Related]
17. Phagocytic killing of Candida albicans by different murine effector cells.
Baccarini M; Blasi E; Puccetti P; Bistoni F
Sabouraudia; 1983 Dec; 21(4):271-86. PubMed ID: 6362037
[TBL] [Abstract][Full Text] [Related]
18. IL-33 Coordinates Innate Defense to Systemic
Nguyen NZN; Tran VG; Baek J; Kim Y; Youn EH; Na SW; Park SJ; Seo SK; Kwon B
J Immunol; 2022 Feb; 208(3):660-671. PubMed ID: 35022276
[TBL] [Abstract][Full Text] [Related]
19. Antifungal activity of splenic, liver and pulmonary macrophages against Candida albicans and effects of macrophage colony-stimulating factor.
Roilides E; Lyman CA; Sein T; Gonzalez C; Walsh TJ
Med Mycol; 2000 Apr; 38(2):161-8. PubMed ID: 10817233
[TBL] [Abstract][Full Text] [Related]
20. Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans.
Netea MG; van Tits LJ; Curfs JH; Amiot F; Meis JF; van der Meer JW; Kullberg BJ
J Immunol; 1999 Aug; 163(3):1498-505. PubMed ID: 10415052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
